Concepedia

Publication | Open Access

COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy

DOIFull Paper Access

23

Citations

42

References

2021

Year

Markus Weckmann, Thomas Bahmer, Jannie Marie Bülow Sand, Sarah Rank Rønnow, Martin Pech, Cornelis J. Vermeulen, Alen Faiz, Diana Julie Leeming, M.A. Karsdal, Lars Lunding,
European Respiratory Journal

Abstract

C4Ma3 levels depend on lung mast cell chymase and are increased in a severe, exacerbating allergic asthma phenotype. C4Ma3 may serve as a novel biomarker to predict anti-IgE therapy response.

References

YearCitations

Page 1